comparemela.com

Page 6 - Lavie Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug

The final patient completes Phase I trial enrollment, evaluating safety and tolerability for Biomica s microbiome-based immuno-oncology drug, BMC128 REHOVOT, Israel, Jan. 17, 2024 /PRNewswire/ .

Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024 - Evogene

Rehovot, Israel - - Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. , is gearing up for participation in.

Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024

REHOVOT, Israel , Dec. 21, 2023 /PRNewswire/  Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. , is.

Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation

Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.